Sp655
PANEL DISCUSSION
Date
May 19, 2024
Presenters
Children
University of North Carolina School of Medicine
Tracks
Related Products
THE INDEX OF SEVERITY FOR EOSINOPHILIC ESOPHAGITIS (I-SEE) REFLECTS CLINCOPATHOLOGIC CHANGES OVER TIME IN A PEDIATRIC COHORT
BACKGROUND: Novel treatment options for eosinophilic esophagitis (EoE) are needed. Previous studies have assessed mepolizumab (mepo), a monoclonal antibody against IL-5, with mixed results in EoE, and the efficacy of mepo in an adult and adolescent population has yet to be fully examined…
FLUTICASONE PROPRIONATE ORAL DISINTEGRATING TABLET, APT-1011, IMPROVES FIBROSTENOTIC FEATURES OF STRICTURES AND GRADE 2/3 RINGS IN SUBJECTS WITH EOSINOPHILIC ESOPHAGITIS (EOE)
Esophageal eosinophilic inflammation and remodeling lead to fibrostenosis in many patients with eosinophilic esophagitis (EoE)…
DEVELOPMENT OF A DIGITAL PATHOLOGY ANALYSIS ALGORITHM TO AUGMENT QUANTIFICATION OF PEAK EOSINOPHIL COUNT IN BIOPSIES FROM PATIENTS WITH EOSINOPHILIC ESOPHAGITIS
BACKGROUND: Eosinophil infiltration is a hallmark of eosinophilic esophagitis (EoE). Histologic assessment of esophageal biopsies is required for diagnosis and evaluation of treatment effect. Current diagnostic criteria are based mainly upon a peak eosinophil count (PEC) ≥15…
PANEL DISCUSSION
The field of EoE is undergone remarkable and dramatic changes in the last decade. With the advent of biologics, a better understanding of all current treatment options and how to pick the right option for a given patient is needed…
